Cardiotoxicity from CRT for NSCLC is significant, with 11% experiencing severe CAEs; hs-cTnT levels effectively predict risk, suggesting routine monitoring to improve patient outcomes. Here, TNNT2 is linked to non-small cell lung carcinoma.